SCHEMBL16607175

SCHEMBL16607175

CC(=O)Nc1ccc(C(=O)Nc2ncc(Cc3ccc(F)cc3F)s2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPER1 Q99527 2/20 0.55
HDAC1 Q13547 2/20 0.49
HDAC3 O15379 1/20 0.49
HDAC2 Q92769 1/20 0.49
NCOR2 Q9Y618 1/20 0.49
MAPT P10636 4/20 0.48
LMNA P02545 3/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
ABL1 P00519 1/20 0.48
OGA O60502 3/20 0.47
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16607222 0.80 MAPT (0.78) HDAC1MAPTLMNAMEN1KMT2A
SCHEMBL24953771 0.79 POLB (0.61) GPER1MAPTLMNAMEN1KMT2A
SCHEMBL16607230 0.79 ABL1 (0.67) MAPTLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL16607309 0.78 LMNA (0.61) MAPTLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL16607122 0.78 KDM4E (0.67) HDAC1MAPTLMNAMEN1KMT2A
SCHEMBL16607181 0.77 MEN1 (0.61) MAPTLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL16607214 0.75 LMNA (0.59) MAPTLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL21394793 0.74 GPER1 (0.51) GPER1MAPTLMNAMEN1KMT2A
SCHEMBL29354643 0.74 GPER1 (0.51) GPER1MAPTLMNAMEN1KMT2A
SCHEMBL24953677 0.73 GPER1 (0.50) GPER1MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-08-04 US disclosed
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2019-04-23 US disclosed
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-09-15 US disclosed
US-9364472-B2 Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof NEW YORK UNIVERSITY (US) 2016-06-14 US disclosed
US-9353078-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof NEW YORK UNIVERSITY (US) 2016-05-31 US disclosed
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-04-14 US disclosed
WO-2015050984-A1 AMINO, AMIDO, AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2015-04-09 WO disclosed
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2015-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 GPER1 258/4885HDAC1 4287/4885HDAC3 3382/4885
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof AGER, IAPP, GPR119 GPER1 258/4885HDAC1 4287/4885HDAC3 3382/4885
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 GPER1 258/4885HDAC1 4287/4885HDAC3 3382/4885
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 GPER1 258/4885HDAC1 4287/4885HDAC3 3382/4885
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof AGER, IAPP, GPR119 GPER1 258/4885HDAC1 4287/4885HDAC3 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.